{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "59676-030",
      "generic_name": "Erdafitinib",
      "labeler_name": "Janssen Products LP",
      "brand_name": "BALVERSA",
      "active_ingredients": [
        {
          "name": "ERDAFITINIB",
          "strength": "3 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "59676-030-56",
          "description": "1 BOTTLE in 1 CARTON (59676-030-56)  / 56 TABLET, FILM COATED in 1 BOTTLE",
          "marketing_start_date": "20190412",
          "sample": false
        },
        {
          "package_ndc": "59676-030-84",
          "description": "1 BOTTLE in 1 CARTON (59676-030-84)  / 84 TABLET, FILM COATED in 1 BOTTLE",
          "marketing_start_date": "20190412",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Janssen Products LP"
        ],
        "rxcui": [
          "2123131",
          "2123137",
          "2123139",
          "2123141",
          "2123143",
          "2123145"
        ],
        "spl_set_id": [
          "2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175605",
          "N0000194026",
          "N0000182141",
          "N0000185506",
          "N0000185503",
          "N0000187061"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Fibroblast Growth Factor Receptor Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Organic Cation Transporter 2 Inhibitors [MoA]"
        ],
        "unii": [
          "890E37NHMV"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "41ec18e6-999d-f298-e063-6294a90aa2dc",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20190412",
      "product_id": "59676-030_41ec18e6-999d-f298-e063-6294a90aa2dc",
      "application_number": "NDA212018",
      "brand_name_base": "BALVERSA",
      "pharm_class": [
        "Cytochrome P450 3A4 Inducers [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "Fibroblast Growth Factor Receptor Inhibitors [MoA]",
        "Kinase Inhibitor [EPC]",
        "Organic Cation Transporter 2 Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}